Published on Roswell Park Cancer Institute (http://www.roswellpark.org)

Assistant Professor of Oncology
Department of Pharmacology and Therapeutics
Roswell Park Cancer Institute
Background Information
Education and Training: 
PhD - 2009 - State University of New York at Buffalo, Roswell Park Cancer Institute Division
Professional Experience: 
2010-2012 - Postdoctoral Associate, Roswell Park Cancer Institute, Buffalo, NY
2009-2010 - Postdoctoral Fellow, Roswell Park Cancer Institute, Buffalo, NY
2009 - Christine Mirzayan Science and Technology Policy Graduate Fellow, The National Academies, Washington, DC
Honors and Awards: 
2012 - AACR Scholar-in-Training Award
2011 - AACR Associate Member Council - Term 2012-2015
2010 - AACR Workshop on Translational Cancer Research for Basic Scientist
2009 - SUNY Buffalo/RPCI Award for Overall Excellence in Dissertation Research
2009 - National Academies Christine Mirzayan Science and Technology Policy Graduate Fellowship Program
2008 - AACR Edward A. Smuckler Memorial Pathobiology of Cancer Workshop
2008 - Keystone Symposia Scholarship
Professional Memberships: 
American Association for Cancer Research (AACR)
American Society of Human Genetics (ASHG)
American Society of Preventive Oncology (ASPO)
American Association for the Advancement of Science (AAAS)
European Association for Cancer Research (EACR)
Epigenetics Society
Women in Cancer Research
Publications
Publications: 
  • Woloszynska-Read A, James SR, Song C, Jin B, Odunsi K, Karpf AR. BORIS/CTCFL expression is insufficient for cancer-germline antigen gene expression and DNA hypomethylation in ovarian cell lines. Cancer immunity 2010; 10:6
  • Karpf AR. BORIS/CTCFL expression is insufficient for cancer-germline antigen gene expression and DNA hypomethylation in ovarian cell lines. Cancer immunity 2010; 10 :6
  • Link PA, Gangisetty O, James SR, Woloszynska-Read A, Tachibana M, Shinkai Y, Karpf AR. Distinct roles for histone methyltransferases G9a and GLP in cancer germ-line antigen gene regulation in human cancer cells and murine embryonic stem cells. Molecular cancer research : MCR 2009; 7(6):851-862
  • Woloszynska-Read A, Odunsi K, Godley LA, Ostler KR, Akers SN, Collamat G, Mhawech-Fauceglia P, Link PA, Yu J, Zhang W, Karpf AR. Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stage. Clinical cancer research 2011; 17(8):2170-2180
  • Woloszynska-Read A, Mhawech-Fauceglia P, Yu J, Odunsi K, Karpf AR. Intertumor and intratumor NY-ESO-1 expression heterogeneity is associated with promoter-specific and global DNA methylation status in ovarian cancer. Clinical cancer research 2008; 14(11):3283-3290
  • Woloszynska-Read A, James SR, Link PA, Yu J, Odunsi K, Karpf AR. DNA methylation-dependent regulation of BORIS/CTCFL expression in ovarian cancer. Cancer immunity 2007; 7:21
  • Woloszynska-Read A, Johnson CS, Trump DL. Vitamin D and cancer: Clinical aspects. Best practice and research. Clinical endocrinology and metabolism 2011; 25(4):605-615
  • James SR, Woloszynska-Read A, Link PA, Karpf AR. Epigenetic regulation of brother of the regulator of imprinted sites (BORIS/CTCFL) by DNA methyltransferase enzymes. Proceedings of the American Association for Cancer Research Annual Meeting 2007; 48:677
  • Woloszynska-Read A, Mhawech-Fauceglia P, Yu J, Odunsi K, Karpf AR. Epigenetic regulation of NY-ESO-1 in ovarian cancer. Proceedings of the American Association for Cancer Research Annual Meeting 2007; 48:679
Source URL (retrieved on 05/26/2013 - 2:15am): http://www.roswellpark.org/anna-woloszynska-read